Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<p>We remain skeptical of the market's upside potential, as we are not sure if anything actually changed in Fed policy, or as a result of the U.S./China trade ceasefire, which has seemingly raised more questions than answers. With that said, 2,817 remains the key resistance level in focus on the S&amp;P 500. In today’s report we highlight attractive opportunities within Airlines, and Home Health Care Services.</p>

We remain skeptical of the market's upside potential, as we are not sure if anything actually changed in Fed policy, or as a result of the U.S./China trade ceasefire, which has seemingly raised more questions than answers. With that said, 2,817 remains the key resistance level in focus on the S&amp;P 500. In today’s report we highlight attractive opportunities within Airlines, and Home Health Care Services.

U.S. Equity Strategy: S&P 500 Fails at Resistance

United States

LHC Group Inc. provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. The company provides home-based services through home nursing agencies and hospices and facility-based services through long-term acute care hospitals and  outpatient rehabilitation clinics.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Lhc Group Inc (LHCG US)

U.S. Equity Strategy: S&P 500 Fails at Resistance

We remain skeptical of the market's upside potential, as we are not sure if anything actually changed in Fed policy, or as a result of the...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)